Anzeige
Mehr »
Dienstag, 21.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoEvercore ISI reiterates Honeywell stock rating on portfolio sale
MoStifel raises Rocket Lab stock price target to $105 on space growth
MoInforma TechTarget expands financial services coverage to UK
MoWSFS Financial renews lease for Philadelphia office space
MoCosmos Health to begin Liv18 liver supplement production in April
MoWhy is Adobe stock climbing today?
MoScotiabank raises Nutrien stock price target on nitrogen business outlook
MoScotiabank cuts Mosaic stock price target on margin pressures
MoBTIG raises Nektar Therapeutics price target to $178 on trial data
MoBarclays cuts RadNet stock price target on consumer uncertainty
MoLeerink reiterates Agios Pharma stock rating amid rival drug data
MoSila Realty Trust stock rises as Blue Owl agrees to acquire REIT
MoScotiabank raises CF Industries stock price target on nitrogen supply outlook
MoClear Street reiterates Comstock Resources stock rating ahead of earnings
MoDoximity stock holds Strong Buy at Raymond James after CFO exit
MoMarriott Vacations completes $460M loan securitization
MoMassimo Group names Quenton Petersen as new CEO
MoCloudflare and GoDaddy partner on AI crawler controls
MoScotiabank reiterates AST SpaceMobile stock underperform on mission concerns
MoStifel reiterates Fermi stock rating on strategic restructuring
MoUBS reiterates PPL stock rating on Rhode Island rate case progress
MoRayonier Advanced Materials stock holds Outperform at RBC on strategy review
MoUBS reiterates Merck stock rating on pipeline strength
MoUBS reiterates Hasbro stock rating on Wizards strength outlook
MoJefferies reiterates Buy on Nektar stock after alopecia trial data